Log in to save to my catalogue

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis...

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1551633011

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis

About this item

Full title

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

Journal title

Gut, 2013-05, Vol.62 (5), p.760-765

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and British Society of Gastroenterology

More information

Scope and Contents

Contents

Objective Entecavir (ETV) is a potent inhibitor of viral replication in chronic hepatitis B and prolonged treatment may result in regression of fibrosis. The aim of this study was to investigate the effect of ETV on disease progression. Design In a multicentre cohort study, 372 ETV-treated patients were investigated. Clinical events were defined as...

Alternative Titles

Full title

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1551633011

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1551633011

Other Identifiers

ISSN

0017-5749

E-ISSN

1468-3288

DOI

10.1136/gutjnl-2012-302024

How to access this item